Clinical Trials
4 trialsNCT07551414 2026-04-24
Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT06971406 2025-05-14
FLAME-1
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT06861218 2025-03-06
Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases
Zhejiang Cancer Hospital
Phase 2 Not yet recruiting
NCT06441045 2024-06-04
Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI
Fujian Cancer Hospital
Phase 2 Not yet recruiting